Geftinat 250mg, Gefitinib of Natco, Genric Iressa
Geftinat 250mg is a cancer chemotherapy medication. Gefitinib interferes with the growth of cancer cells and slows their growth and spread in the body.
Geftinat 250mg is used in the treatment of non-small cell lung cancer.
 |
| Geftinat 250mg by Natco |
Possible side effects of Geftinat gefitinib 250mg ( Genric Iressa)
If you experience any of the following serious side effects from Geftinat, contact your doctor immediately:- an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
- lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
- severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
- eye pain or irritation.
- mild to moderate nausea, vomiting, loss of appetite, or diarrhea;
- skin rash, dryness, itching, or acne; or
- weakness.
Most important information I should know about Geftinat 250mg
Geftinat 250mg should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.Serious side effects have been reported with the use of gefitinib including: allergic reactions (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives); lung problems; liver problems; eye problems; severe nausea, vomiting, loss of appetite, or diarrhea; and others. Talk to your doctor about the possible side effects from treatment with geftinat 250mg .
